United Therapeutics Corporation Reports Fourth Quarter and Full Year 2022 Financial ResultsBusiness Wire • 02/22/23
United Therapeutics Corporation to Report Fourth Quarter and Full Year 2022 Financial Results Before the Market Opens on Wednesday, February 22, 2023Business Wire • 02/15/23
After Plunging -5.18% in 4 Weeks, Here's Why the Trend Might Reverse for United Therapeutics (UTHR)Zacks Investment Research • 01/19/23
United Therapeutics Corporation to Present at the 41st Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 01/02/23
United Therapeutics Named by Newsweek as One of America's Most Responsible Companies 2023Business Wire • 12/08/22
Why Is United Therapeutics (UTHR) Up 3.8% Since Last Earnings Report?Zacks Investment Research • 12/02/22
Can United Therapeutics (UTHR) Run Higher on Rising Earnings Estimates?Zacks Investment Research • 11/10/22
United Therapeutics Corporation to Present at the Credit Suisse 31st Annual Healthcare ConferenceBusiness Wire • 11/01/22
United Therapeutics Announces Top Line Data From the EXPEDITE Study of Remodulin Induction Prior to Orenitram TherapyBusiness Wire • 10/31/22
United Therapeutics Corporation to Report Third Quarter 2022 Financial Results Before the Market Opens on Wednesday, November 2, 2022Business Wire • 10/26/22